valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

HERBALIFE LTD. (HLF) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$14.00 ComplexityHigh Updated
$13.00 $59.00
bear $13.00 base $36.00 bull $59.00 margin of safety $14.00 market price* $14.60
Business condition attached to the margin of safety Worldwide net sales in constant currency still growing year over year in the first full quarter reported after the CEO change (the fourth-quarter 2026 results), showing that India and Latin America growth is still more than offsetting declines in North America, Europe/Middle East/Africa and China during the leadership transition.
Herbalife sells protein shakes, meal replacements and other nutrition products through a multi-level marketing network: independent distributors buy product at a discount, resell it (often through small neighborhood "nutrition clubs"), and earn commissions on sales made by people they recruit. Net sales were $5.04 billion in 2025. Weight-management products are still 54.5% of sales, and that category has been shrinking slowly ($2.85 billion in 2023, $2.75 billion in 2025). The multi-level marketing structure matters to the value, and we have tried to price it rather than wave it away. Three things follow from it. First, sales depend on a network of people who can leave, and a country's network can peak and then shrink for years. That has already happened: North American sales leaders fell from about 69,600 to 52,900 between early 2023 and early 2025, and North American sales fell from roughly $1.5 billion in the 2021 pandemic peak to $1.03 billion in 2025. In China, sales leaders fell from 38,300 to 22,100, and China sales dropped 29% in constant currency in the second quarter of 2026. Second, regulators restrict the model. Since a 2016 settlement with the Federal Trade Commission (which included a $200 million payment), Herbalife may only pay U.S. distributors on verified sales to customers and on their own consumption within limits, and it may not make income or lifestyle claims. That order is permanent. Third, some of the network numbers are softer than they look: the company says it has lowered the sales volume distributors need to keep sales-leader status in more and more markets, so improving retention rates (North America 77.8% in 2026, up from 70.3% in 2024) partly reflect an easier test. The other side is equally factual. The company has operated since 1980 and has survived repeated regulatory and short-seller campaigns. Revenue has stayed between $4.4 billion and $5.8 billion for the past decade. Growth has moved to newer markets: India reached $890 million of sales in 2025 and grew 47% in constant currency in the second quarter of 2026, and Latin America has had four straight quarters of double-digit reported growth. Total sales grew 6.6% in the first half of 2026, the fourth straight quarter of growth. North America was flat in the second quarter. How we measured earnings. We use owner earnings: cash from operations, excluding swings in inventory and receivables, minus stock compensation and minus the capital spending needed to keep the business running. These were $2.37 per share in 2025, $0.80 in 2024, $1.27 in 2023 and $2.76 in 2022. Earlier years were higher ($3.28 in 2020 and $4.43 in 2021), but they came from a larger North American business, the pandemic boom, and interest costs that were much lower before the debt-funded buybacks of 2018-2021. Cash interest paid rose from $45 million in 2016 to $206 million in 2025. We therefore measure from 2022 onward, the business as it exists today. The median of those four years is $1.82 per share. Part of that low figure comes from one-time items in 2023-2024: about $54 million of restructuring costs in 2023, and $122-135 million a year of capital spending while the company built its "Herbalife One" distributor technology platform. Capital spending has since fallen to $80 million in 2025 and $50-70 million planned for 2026. We made one adjustment against the company: the cash-flow statement adds back inventory write-downs ($28.5 million, $18.9 million and $25.9 million in 2023-2025), and this happens every year, so we treat about $24 million a year as a real ongoing cost. The second-quarter 2026 net loss of $26 million was not an operating problem. In April 2026 Herbalife refinanced $1.165 billion of its most expensive debt: 12.25% secured notes (redeemed at 106.125%) and a term loan costing about 11.6%. It replaced them with $800 million of 7.75% secured notes due 2033 plus a bank term loan and revolving credit line. The early-redemption premium and write-offs produced a $94.6 million non-cash accounting loss. The company expects the refinancing to save about $45 million a year in cash interest, and quarterly interest expense has already fallen from $54 million to $37 million. Operating income was $481 million in 2025 (up from $356 million in 2023) and $267 million in the first half of 2026. Debt is still large at about $2.04 billion. We did not subtract it from the value, because owner earnings are measured after interest. The debt is priced into the cases instead. Starting point. On 2025 cash flows, less the recurring inventory cost, plus the after-tax interest saving, the business earns roughly $2.35-2.45 per share over the next two years. That is well above the $1.82 median, for the specific reasons above: one-time platform spending has ended, restructuring costs have ended, and cheaper debt is in place. Owner-earnings growth in 2025 was unusually high (from $0.80 to $2.37) because it bounced off a trough, and we do not project that bounce forward. Base case, about $36 per share. India and Latin America keep offsetting North America, European and Chinese erosion, so total earnings stay roughly flat. Owner earnings are about $2.35-2.43 per share in the next two years. They dip to about $2.24 in 2028-2029, when the $277.5 million of 4.25% convertible notes due 2028 and the roughly $600 million of 4.875% notes due 2029 are assumed to be refinanced near the 7.75% rate the company just paid. After that they grow about 1% a year through year 10. Beyond year 10 we assume a slow 1% annual decline rather than permanence. Operating income has fallen from $584 million in 2015 to $481 million in 2025, and the core weight-management category is shrinking, so the evidence supports a long life but not growth. Bear case, about $13 per share. Growth in India and Latin America stalls. This is a real risk: part of India's recent surge followed a September 2025 cut in India's consumer sales tax that lowered retail prices, and that boost will not repeat. Meanwhile North America, Europe and China keep shrinking at their recent pace. Earnings fall back toward the 2023-2024 trough within about three years. The 2028-2029 debt then has to be refinanced at the roughly 12% the company was forced to pay in 2024, which takes about $0.45 per share a year more from shareholders. Owner earnings drop to about $1.05 per share by year four and then shrink 5% a year indefinitely, like a slowly unwinding network. The shares still carry positive value in this case because the debt stays serviceable, but only just. Bull case, about $59 per share. The international growth of the past four quarters continues at a slower but still solid pace. Sales grow about 5% a year, near the top of the company's 2026 range, and the high 78% gross margin lets profits grow faster than sales. Owner earnings grow about 7% a year for four years and 3% a year to year 10, reaching about $3.80 per share. That would put operating income back in the $600-700 million range the company actually earned in 2017-2021. We assume no growth after year 10. What has changed since our previous analysis. We previously put the base case at $56. We lowered it for four reasons. (1) The earlier starting point of $2.65 per share included the pandemic boom and a much larger North American business, which no longer describe the company. (2) We now count recurring inventory write-downs as a cost. (3) We no longer assume earnings stay flat forever after year 10. The decade-long decline in operating income argues against that. (4) The earlier bear case of $31 was too mild for a business that earned just $0.80 per share in 2024. Two facts moved the other way and are now included: the April 2026 refinancing, which the earlier analysis did not account for, cuts interest costs by about $45 million a year, and the second-quarter loss that was previously unexplained turns out to be a one-time accounting charge from that refinancing. What would make this wrong. The business is not collapsing today. Sales, operating income and cash flow all rose in 2025 and the first half of 2026. But a network business can turn quickly, as North America did in 2022-2024. Chief executive Stephan Gratziani leaves at the end of October 2026; the CFO becomes interim CEO and a new CFO starts in January 2027. Growth is increasingly concentrated in India, where the company also has disputed tax assessments. If the network starts shrinking company-wide during this transition, the bear case becomes the likely outcome. Because of the leverage, the dependence on a network of independent sellers and the regulatory history, the margin-of-safety price sits at a large discount to the base case: about 60%, which keeps it close to the bear-case value.
Fiscal yearOwner's earningsMethodology
2025 $2.37 ▼
OE = CFO - ΔWC - SBC - maintenance capex. CFO=$333.3M; ΔWC = receivables $(19.7)M + inventories $(27.9)M + prepaid $13.0M + AP $24.1M + member compensation liabilities $23.5M + other current liab. $(36.2)M + other $(12.3)M = $(35.5)M (net use, added back); SBC=$44.1M; capex=$80.4M (capex normalizing lower as the multi-year Herbalife One digital platform build is substantially complete); revenue grew from $4,993.1M to $5,037.5M (+$44.4M); growth capex=2.361%x44.4=$1.0M, maintenance capex=80.4-1.0=$79.4M; OE=333.3+35.5-44.1-79.4=$245.3M; diluted shares=103.6M; OE/sh=$2.37. Independent reconciliation (NI $227.8M + D&A $121.2M + SBC $44.1M + non-cash interest $16.4M - deferred taxes $64.2M + inventory write-downs $25.9M + FX loss $0.8M + other $(3.2)M + ΔWC $(35.5)M - maintenance capex $79.4M = CFO-based OE within <1%). Source: FY2025 10-K, accession 0001193125-26-057113.
2024 $0.80 ▼
OE = CFO - ΔWC - SBC - maintenance capex. CFO=$285.4M; ΔWC = receivables $5.9M + inventories $(30.4)M + prepaid $43.1M + AP $(14.6)M + member compensation liabilities $6.5M + other current liab. $45.0M + other $(23.0)M = $32.5M (net source, subtracted); SBC=$50.0M; capex=$122.0M; revenue declined from $5,062.4M to $4,993.1M so growth capex=$0, maintenance capex=$122.0M; OE=285.4-32.5-50.0-122.0=$80.9M; diluted shares=101.6M; OE/sh=$0.80. FY2024 also included an unusually large $(229.6)M deferred-tax benefit that lifted reported net income without affecting CFO/OE; reconciliation (NI+D&A+all non-cash items+ΔWC) ties to CFO within rounding, confirming this year's low OE is a genuine cash-flow trough (weak CFO plus still-elevated Herbalife One platform capex), not a tagging error. Source: FY2025 10-K, accession 0001193125-26-057113.
2023 $1.27 ▼
OE = CFO - ΔWC - SBC - maintenance capex. CFO=$357.5M; ΔWC = receivables $(12.6)M + inventories $57.5M + prepaid $(13.8)M + AP $(7.4)M + member compensation liabilities $(7.3)M + other current liab. $24.6M + other $6.7M = $47.7M (net source, subtracted); SBC=$48.0M; capex=$135.0M; revenue declined from $5,204.4M to $5,062.4M so growth capex=$0, maintenance capex=$135.0M; OE=357.5-47.7-48.0-135.0=$126.8M; diluted shares=100.2M; OE/sh=$1.27 (cycle trough, continued distributor-count decline post-COVID). Source: FY2025 10-K, accession 0001193125-26-057113 (3-year comparative statement, latest restated).
2022 $2.76 ▼
OE = CFO - ΔWC - SBC - maintenance capex. CFO=$352.5M; ΔWC = receivables $(9.1)M + inventories $(68.4)M + prepaid $(12.4)M + AP $(1.1)M + royalty overrides $(9.6)M + other current liab. $(53.6)M + other $31.1M = $(123.1)M (net use, added back); SBC=$44.4M; capex=$156.4M; revenue declined from $5,802.8M to $5,204.4M (post-COVID normalization) so growth capex=$0, maintenance capex=$156.4M; OE=352.5+123.1-44.4-156.4=$274.8M; diluted shares=99.5M; OE/sh=$2.76. Source: FY2023 10-K, accession 0000950170-24-015266 (3-year comparative statement).
2021 $4.43 ▼
OE = CFO - ΔWC - SBC - maintenance capex. CFO=$460.3M; ΔWC = receivables $9.6M + inventories $(129.1)M + prepaid $(49.3)M + AP $6.9M + royalty overrides $17.8M + other current liab. $(68.8)M + other $(5.4)M = $(218.3)M (large net use of cash - inventory build and distributor royalty timing - added back); SBC=$54.1M; capex=$151.4M; revenue grew from $5,541.8M to $5,802.8M (COVID-era peak, +$261.0M); growth capex=2.361%x261.0=$6.2M, maintenance capex=151.4-6.2=$145.2M; OE=460.3+218.3-54.1-145.2=$479.3M; diluted shares=108.3M; OE/sh=$4.43 (cycle peak). Source: FY2021 10-K, accession 0000950170-22-001787.
2020 $3.28 ▼
OE = CFO - ΔWC - SBC - maintenance capex. CFO=$628.6M; ΔWC = receivables $(5.8)M + inventories $(76.6)M + prepaid $(11.9)M + AP $5.5M + royalty overrides $61.2M + other current liab. $77.6M + other $(9.8)M = $40.2M (net source, subtracted); SBC=$51.0M; capex=$112.0M; revenue grew from $4,877.1M to $5,541.8M (+$664.7M, COVID-era demand surge); growth capex=2.361%x664.7=$15.7M, maintenance capex=112.0-15.7=$96.3M; OE=628.6-40.2-51.0-96.3=$441.1M; diluted shares=134.5M; OE/sh=$3.28. Source: FY2021 10-K, accession 0000950170-22-001787.
2019 $2.65 ▼
OE = CFO - ΔWC - SBC - maintenance capex. CFO=$457.5M; ΔWC = receivables $(14.4)M + inventories $(68.6)M + prepaid $28.3M + AP $0.1M + royalty overrides $11.5M + other current liab. $(5.5)M + other $(13.6)M = $(62.2)M (net use, added back); SBC=$38.6M; capex=$106.1M; revenue declined vs 2018 ($4,877.1M vs $4,891.8M) so growth capex=$0, maintenance capex=$106.1M; OE=457.5+62.2-38.6-106.1=$375.0M; diluted shares=141.6M; OE/sh=$2.65. Source: FY2021 10-K, accession 0000950170-22-001787 (3-year comparative statement).
2018 $3.08 ▼
OE = CFO - ΔWC - SBC - maintenance capex. CFO=$648.4M; ΔWC = receivables $2.8M + inventories $(83.3)M + prepaid $(5.1)M + AP $21.7M + royalty overrides $22.8M + other current liab. $106.8M + other $13.5M = $79.2M (net source, subtracted); SBC=$35.5M; capex=$84.0M; revenue grew from $4,427.7M to $4,891.8M (+$464.1M); capex_ratio (mean capex/revenue, 2019-2025 window)=2.361%, growth capex=2.361%x464.1=$11.0M, maintenance capex=84.0-11.0=$73.0M; OE=648.4-79.2-35.5-73.0=$460.7M; diluted shares=149.5M; OE/sh=$3.08. Source: FY2018 10-K, accession 0001564590-19-003287.
2017 $2.42 ▼
OE = CFO - ΔWC - SBC - maintenance capex. CFO=$590.8M; ΔWC = receivables $(22.2)M + inventories $37.9M + prepaid $38.3M + AP $(5.0)M + royalty overrides $6.0M + other current liab. $(17.1)M + other $14.1M = $52.0M (net source of cash, removed by subtracting $52.0M); SBC=$42.1M; capex=$95.5M; revenue declined vs 2016 ($4,427.7M vs $4,488.4M) so growth capex=$0, maintenance capex=total capex=$95.5M; OE=590.8-52.0-42.1-95.5=$401.2M; diluted shares=165.7M (post-split); OE/sh=$2.42. Source: FY2018 10-K, accession 0001564590-19-003287.
2016 $1.41 ▼
OE = CFO - ΔWC - SBC - maintenance capex. CFO=$367.3M; ΔWC (changes in operating assets/liabilities per CF statement: receivables ~$0, inventories $(71.6)M, prepaid $0.8M, AP $(1.3)M, royalty overrides $20.9M, other current liabilities $12.4M, other $(19.5)M) = $(58.3)M (a net use of cash, so removed by adding back $58.3M); SBC=$40.2M; capex=$143.4M; prior-year revenue unavailable in source data so growth capex not computed, maintenance capex conservatively set to total capex=$143.4M; OE=367.3+58.3-40.2-143.4=$242.0M; diluted shares=172.2M (post 2-for-1 split, as restated in later filings); OE/sh=$1.41. Source: FY2018 10-K, accession 0001564590-19-003287 (3-year comparative statement).

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
Worldwide across about 95 countries. 2025 net sales: Asia Pacific about 34% (India alone about 18%, Vietnam about 6%), Europe/Middle East/Africa about 22%, North America about 21% (mostly the United States), Latin America about 17% (led by Mexico), and China about 6%. India and Latin America are the growing regions; the United States, Europe and China are shrinking or flat.
Historical growth strategy

We don't have historical growth strategy information for this company yet.

Chart analysis

We don't have chart analysis for this company yet.

Competitors

We don't have competitor information for this company yet.

Circle of competence

We don't have circle of competence information for this company yet.